David D. McManus appointed chancellor of UMass Chan Medical School The UMass Board of Trustees unanimously approved UMass President Marty Meehan’s nomination of David D. McManus, MD’02, MSc’12, as the next chancellor of UMass Chan.

UMass President Marty Meehan just announced that David McManus, MD’02, MSc’12, will be the next chancellor of UMass Chan Medical School: direc.to/o2AM

Dr. McManus will succeed Chancellor Michael F. Collins in July after Collins retires as chancellor. Congratulations!

#UMass @uofmass.bsky.social

❤️

Happy holidays from the coolest CVM research trainees around!🧑‍🔬👨‍🔬👩‍🔬 Wishing you a wonderful 2026!!!

You Just Found Out You Have High Triglycerides—Here Are 6 Things Cardiologists Recommend Doing If you just found out you have high triglycerides, these cardiologist-backed tips can help bring down your numbers for better long-term heart health.

www.eatingwell.com/things-to-do...

Wonderful time at #AHA25 @ahascience.bsky.social ! Couldn’t be more excited about the science and friends we saw. See everyone at #AHA26, or perhaps in @bcvs first. 😁

OSA and POAF ⬇️⬆️➡️ What’s the relationship!? Think you know until you see the data. Check out @tay_orw poster #TranLab @ahascience.bsky.social It’s her scientific question ✨🤩 #HEATAF @umasschan.bsky.social

Congratulations, @spjuraschek.bsky.social (and his mighty team!) for your GoFresh late breaker at #AHA25 and your @jama.com publication! Huge amount of work and very impressive findings.

@bidmcreseach.bsky.social
jamanetwork.com/journals/jam...

Catch you in 203-205!!! #AHA25

Calling all coffee drinkers! Dr. Khan has good news from the DECAF trial presented at #AHA25. ☕☕☕

📢 Adding evolocumab to lipid-lowering therapy significantly reduced the risk of a first major CV event in patients without prior heart attack or stroke.

#AHA25 ⬇️

Incredibly exciting and helpful updates in our space from Dr Tsimikas! (UMass Chan alum 😁) #APOC3 #sTG #AHA25

H5 effect on HUVECS. 🧐I think the endothelial cell is pretty awesome too. We should all study adipocytes and endothelial cells!

PPARG and Adipogenesis 😁

So excited to start this morning! Look at those lipid droplets. Join in the 206-207! #HDLsubfraction #molmed #AHA25

Here’s a throwback!!! #fellow-to-faculty #oldfriends @apfenniger.bsky.social #AHA25 #rememberWhen

VESALIUS-CV results presented at #AHA25

VESALIUS-CV results presented at #AHA25

ANGPTL3 results presented at #AHA25

ANGPTL3 results presented at #AHA25

Starting NOW in 203-205! #transcriptomics #targetsfromtheBench

Geeking out perivascular adipose tissue! #PVATcrosstalk #PVAT-CVD #AHA25

This lecture by Dr. Packer is beyond cool. It’s fascinating how sensitive the heart is to fat. What’s the crosstalk? 🤔

Kicking off in Rivergate! ADIPOKINE and HFpEF. Can listen and talk about this all day 😁 #soCool #adiposebiology

Happening NOW! Crosstalk 🤔

Remarkable, groundbreaking progress for cardiometabolic science and medicine!!! #FGF21R #GLP1 #APOC3 #ANGPTL3 #PCSK9 #mAb #siRNA #ASO #CRISPRCas9
Shoutout to ♥️ basic and clinical scientists moving this forward for our patients! @ahascience.bsky.social #AHA25 #PrevCards #Lipidology

Kicking off the day!!! #AHA25

Red Vans on the floor
MD/PhD 👟 still mine
AHA, let’s go!!! #OldFriends #sneakerMonday #AHA25 @ahascience.bsky.social

Here’s Katherine, MS4, presenting on lipid-lowering therapy in patients with cardiometabolic disease at #CMHC2025. So cool. And she rocks! ⭐️

HAPPENING NOW!!!

Happy 12th anniversary to my A-1 Reviewer, Figure 1 screener, in-house counsel, and always my friend at the end of the day. Thank you for helping me see the humor in life. My favorite projects in life are with you. ❤️

What an amazing lecture on GLP1RA therapy by Dr. Plutzky! 😁Love focusing on adipose biology and open access. #ASPC2025

So proud of Elisa presenting our data on statin adherence from our center at #ASPC2025 Congress on #CVDPrevention. Love “flipping the script” and focusing on prevention. Cool!